Blood Ratios and Stroke Severity: What Researchers Found

What the researchers wanted to know

Doctors treat strokes as medical emergencies, but it helps to know right away how severe a stroke might be so they can plan the best care. Researchers at a center publishing in eNeurologicalSci wondered whether two simple blood ratios—comparing certain white blood cells to HDL cholesterol—could signal how serious an acute ischemic stroke (the most common type) would turn out to be.

The two ratios they studied were the monocyte-to-HDL ratio (MHR) and the neutrophil-to-HDL ratio (NHR). Both ratios combine counts of immune cells with a type of cholesterol measured in blood work.

Who was in the study and what they measured

This was a cross-sectional study—a snapshot in time—at a single center. Adult patients who had suffered an acute ischemic stroke were grouped into two categories: those with mild strokes and those with moderate-to-severe strokes, using a standard tool called the National Institute of Health Severity Scale (NIHSS).

The team collected blood samples and measured immune cell counts, cholesterol levels, and other markers. They then looked for connections between these blood measures and how severe each patient's stroke turned out to be.

What they found

The monocyte-to-HDL ratio (MHR) was statistically higher in the group with more severe strokes compared to the mild stroke group. When researchers looked at the correlation between MHR and stroke severity scores, they found a weak but statistically significant relationship—meaning the ratio trended upward as stroke severity increased, though the relationship was not strong.

However, when the researchers dug deeper using more rigorous statistical methods, the picture became murkier. When they adjusted for other factors, MHR no longer appeared to independently predict stroke severity. The ability of MHR alone to distinguish mild from severe strokes was modest at best.

What these blood markers might signal

The study involved several blood markers that clinicians routinely measure: HDL cholesterol, triglycerides, total cholesterol, uric acid, and hs-CRP (a measure of inflammation). When stroke patients were compared, differences in these markers appeared between the mild and moderate-severe groups. These are markers a clinician might discuss with you as part of a full picture of your health, especially after a stroke event. None of these findings should prompt you to seek testing on your own or interpret any single marker in isolation.

Why this study matters—and what it doesn't prove

Simple, inexpensive blood tests that could hint at stroke severity would be valuable for doctors making quick decisions. This study suggests MHR might eventually play a role in that toolkit. But the evidence here is early and not conclusive. The researchers themselves noted that MHR alone was not a strong independent predictor when other factors were controlled for.

It's also important to remember this was a single-center study at one point in time, not a large multicenter trial following patients over months or years. Before any blood ratio becomes a standard tool for predicting stroke severity, much larger and more rigorous studies would be needed.

The takeaway

This research opens a door: simple blood ratios like monocyte-to-HDL might someday help doctors gauge stroke severity. But the connection found here was weak, and the ratio did not independently predict severity when researchers looked more carefully. Further research is needed before any such test could be relied upon as a standalone indicator. If you've had a stroke or are at risk, the most important step is working closely with your doctor, who uses proven clinical assessment tools along with any relevant blood work to guide your care.

What this means for you

A study in eNeurologicalSci found a weak connection between the monocyte-to-HDL cholesterol ratio and acute stroke severity, but the link did not hold up when other factors were accounted for. The findings are early and suggest more research is needed before any blood ratio could reliably predict stroke severity on its own.

This summary is for general education, is not medical advice, and does not diagnose or treat any condition. Studies like this describe what researchers observed, not a recommendation for you. Talk with a qualified clinician about your health, and read how we write about research in our editorial policy.